Aurobindo Pharma partners with a global firm to develop respiratory drugs, investing up to $90M.

Aurobindo Pharma, an Indian drugmaker, has teamed up with a major global pharmaceutical company to develop and sell respiratory drugs. Aurobindo will pay up to $90 million for development costs, and both companies will share marketing rights. The unnamed partner will handle manufacturing. This collaboration aims to speed up product launches and enhance Aurobindo's drug offerings.

4 months ago
3 Articles

Further Reading